Rasch analysis of the Fatigue Severity Scale in multiple sclerosis

Multiple Sclerosis

Volumn 15, Issue 1, 2009, Pages 81-87

  Mills, Roger J ^a   Young, C A ^a   Nicholas, R S ^b   Pallant, J F ^c   Tennant, A ^d  

^a WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b CHARING CROSS HOSPITAL   (United Kingdom)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Fatigue; Multiple sclerosis; Rasch; Scale

Indexed keywords

ADULT; AGE; AGED; ARTICLE; DISCRIMINANT VALIDITY; FATIGUE; FATIGUE SEVERITY SCALE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT; PSYCHOMETRY; RASCH ANALYSIS; RATING SCALE; SOCIAL ASPECT; UNITED KINGDOM; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; DISABILITY EVALUATION; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, PSYCHOLOGICAL; MULTIPLE SCLEROSIS; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 58149085437     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458508096215     Document Type: Article

References (26)

1. Multiple Sclerosis Council. Fatigue and multiple sclerosis - clinical practice guidelines. Washington (DC): Paralyzed Veterans of America; 1998.
2. Strober LB Arnett PA. An examination of four models predicting fatigue in multiple sclerosis. Arch Clin Neuropsychol 2005; 20: 631-646.
3. Kos D Kerckhofs E Nagels G D'Hooghe MB Ilsbroukx S. Origin of fatigue in multiple sclerosis: Review of the literature. Neurorehabil Neural Repair 2008; 22: 91-100.
4. Krupp LB. Fatigue in multiple sclerosis: Definition, pathophysiology and treatment. CNS Drugs 2003; 17: 225-234.
5. Krupp LB LaRocca NG Muir-Nash J Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989; 46: 1121-1123.
6. Roelcke U Kappos L Lechner-Scott J. Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: A 18F-fluorodeoxyglucose positron emission tomography study. Neurology 1997; 48: 1566-1571.
7. Rammohan KW Rosenberg JH Lynn DJ Blumenfeld AM Pollak CP Nagaraja HN. Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: A two centre phase 2 study. J Neurol Neurosurg Psychiatry 2002; 72: 179-183.
8. Krupp LB Coyle PK Doscher C. Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo. Neurology 1995; 45: 1956-1961.
9. Schwid SR Covington M Segal BM Goodman AD. Fatigue in multiple sclerosis: Current understanding and future directions. J Rehabil Res Dev 2002; 39: 211-224.
10. Flachenecker P Kumpfel T Kallmann B. Fatigue in multiple sclerosis: A comparison of different rating scales and correlation to clinical parameters. Mult Scler 2002; 8: 523-526.
11. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983; 33: 1444-1452.
12. Krupp LB Alvarez LA LaRocca NG Scheinberg LC. Fatigue in multiple sclerosis. Arch Neurol 1988; 45: 435-437.
13. Rasch G. Probabilistic models for some intelligence and attainment tests. Chicago: Univ. Chicago P.; 1980.
14. Perline R Wright BD Wainer H. The Rasch model as additive conjoint measurement. Appl Psychol Meas 1979; 3: 237-255.
15. Wright BD Linacre JM. Observations are always ordinal; measurements, however, must be interval. Arch Phys Med Rehabil 1989; 70: 857-860.
16. Tennant A Penta M Tesio L. Assessing and adjusting for cross-cultural validity of impairment and activity limitation scales through differential item functioning within the framework of the Rasch model: the PRO-ESOR project. Med Care 2004; 42: I37-I148.
17. Poser CM Paty DW Scheinberg L. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983; 13: 227-231.
18. Tennant A Conaghan PG. The Rasch measurement model in rheumatology: What is it and why use it? When should it be applied, and what should one look for in a Rasch paper. Arthritis Rheum 2007; 57: 1358-1362.
19. Pallant JF Tennant A. An introduction to the Rasch measurement model: An example using the Hospital Anxiety and Depression Scale (HADS). Br J Clin Psychol 2007; 46: 1-18.
20. Smith EV. Detecting and evaluating the impact of multidimensionality using item fit statistics and principal component analysis of residuals. J Appl Meas 2002; 3: 205-231.
21. Tennant A Pallant JF. Unidimensionality matters! (A tale of two Smiths?). Rasch Meas Trans 2006; 20: 1048-1051.
22. Choppin B. A fully conditional estimation procedure for Rasch model parameters (CSE report 196). University of California, center for the study of evaluation; 1983.
23. Linacre JM. Sample size and item calibration stability. Rasch Meas Trans 1994; 7: 28.
24. Confavreux C Vukusic S. Natural history of multiple sclerosis: A unifying concept. Brain 2006; 129: 606-616.
25. Mills RJ Young CA. A medical definition of fatigue in multiple sclerosis. QJM 2008; 101: 49-60.
26. Hagell P Hoglund A Reimer J. Measuring fatigue in Parkinson's disease: A psychometric study of two brief generic fatigue questionnaires. J Pain Symptom Manage 2006; 32: 420-432.